Defeat GBM Research Collaborative: Two-Year Progress Report Where We’ve Been & Where We’re Going: Past Progress and Future Developments Glioblastoma (GBM) is the most common, complex, treatment-resistant, and deadliest type of brain cancer. The pursuit of new and more effective treatments for GBM patients addresses an area of urgent, high-unmet medical need given the lack of effective treatment options currently available. GBM […] March 24, 2016
Innovation, Partnerships & Progress: 2015 Scientific Summit Highlights Scientific research is the backbone of the National Brain Tumor Society’s (NBTS) mission and programs. When our legacy organizations were formed in the 1980’s the general knowledge in the medical and scientific communities regarding brain tumors and how to treat this disease was very minimal. As such, our founders realized the only way to a […] November 3, 2015
Because of You: Closing Out a Fruitful 2013 in Brain Tumor Research The brain tumor community is dedicated to fighting one of the toughest battles imaginable. Thus we are all – from patients, to caregivers, to doctors, to scientists, to advocates – constantly looking forward to the next hurdle we have to jump on our mission toward a cure. Here at the National Brain Tumor Society, specifically, […] December 30, 2013
Defeat GBM Scientific Meeting Overview National Brain Tumor Society launched our Defeat GBM Research Collaborative in March of 2013 to great enthusiasm from both the patient and scientific communities. As our boldest strategic research initiative to-date, the Defeat GBM Research Collaborative aims to double the five-year survival rate of glioblastoma multiforme (GBM) patients in just five years. October 30, 2013
National Brain Tumor Society Participates in Think Tank National Brain Tumor Society and American Association for Cancer Research (AACR) recently partnered to organize a Cancer Systems Biology Think Tank at which world-renowned researchers in the field of cancer systems biology discussed ways to move the field forward to improve the efficiency and success of today’s cancer research enterprise. National Brain Tumor Society and […] January 29, 2013